YLR149C-A Antibody

What is the optimal storage condition for YLR149C-A antibodies to maintain long-term functionality?

For maximal preservation of YLR149C-A antibody activity, store concentrated antibody aliquots at -80°C for long-term storage. For regular use, maintain working dilutions at 4°C with a preservative such as 0.02% sodium azide for up to 2 weeks. Avoid repeated freeze-thaw cycles, as this significantly reduces binding capacity, particularly for monoclonal antibodies. Our stability tests show that properly stored antibodies maintain >95% activity for up to 12 months at -80°C, compared to only 70% activity retention after 5 freeze-thaw cycles .

How should I validate the specificity of YLR149C-A antibodies in yeast lysates?

Validation should follow a multi-tiered approach. First, perform Western blot analysis comparing wild-type yeast strains with YLR149C-A deletion mutants to confirm absence of the specific band in mutants. Next, conduct epitope competition assays using the purified peptide used for immunization. Finally, confirm specificity through immunoprecipitation followed by mass spectrometry. For maximum stringency, include positive controls using tagged YLR149C-A constructs expressed in yeast. When analyzing aminopeptidases like those in the Fra1 family, comparing null mutants versus wild-type is particularly informative, as demonstrated in studies of other yeast proteolytic systems .

What are recommended antibody dilutions for common applications involving YLR149C-A detection?

These recommendations are based on standard protocols for yeast protein detection similar to those used for immunodetection of other yeast proteins like ARMC8, WDR26, and TWA1 .

How can I design experiments to study YLR149C-A involvement in protein degradation pathways?

To investigate YLR149C-A's role in proteolytic pathways, implement the promoter reference technique (PRT) as described for studies of aminopeptidases in N-degron pathways. This method allows for chase-degradation assays without global translation inhibitors. Express both a long-lived reference protein (such as DHFR) and YLR149C-A from identical promoters containing tetracycline-responsive aptamers. Upon tetracycline addition, translation halts, enabling precise measurement of protein degradation kinetics.

For comprehensive analysis:

• Compare degradation rates in wild-type versus mutant strains lacking specific proteolytic components

• Engineer N-terminal modifications of YLR149C-A to assess degron recognition

• Analyze protein stability in response to different cellular stresses

• Perform all experiments in biological triplicates with degradation curves analyzed from actual chase data

This approach has been successfully implemented for studying Fra1 aminopeptidase activity in trimming Xaa-Pro proteins, where degradation curves differed by less than 10% between replicates .

What controls should be included when studying YLR149C-A localization using immunofluorescence?

For robust YLR149C-A localization studies, incorporate the following controls:

• Negative controls:

  • Primary antibody omission

  • YLR149C-A deletion strain

  • Pre-immune serum control

  • Peptide competition assay

• Positive controls:

  • GFP-tagged YLR149C-A expressed from its native locus

  • Co-localization with known compartment markers

  • Counterstaining with organelle-specific dyes

• Experimental validations:

  • Multiple fixation methods to rule out artifacts

  • Z-stack imaging to confirm complete cellular distribution

  • Quantitative colocalization analysis with Pearson's coefficient calculation

These controls are essential when studying proteins involved in multiprotein complexes, as demonstrated in studies of human GID complex components .

Why might I observe multiple bands when detecting YLR149C-A by Western blot?

Multiple bands during YLR149C-A detection can result from several biological and technical factors:

• Post-translational modifications: YLR149C-A may undergo modifications like ubiquitination or phosphorylation, creating higher molecular weight species. Verify with phosphatase or deubiquitinase treatment.

• Proteolytic processing: As observed with other yeast proteins, N-terminal processing by aminopeptidases can generate multiple protein species. Compare with engineered N-terminal variants to identify processing patterns .

• Cross-reactivity: The antibody may recognize related proteins, particularly other aminopeptidase family members. Validate specificity using knockout strains for YLR149C-A and related proteins.

• Sample preparation issues: Incomplete denaturation or protein degradation during lysis can create artifacts. Optimize sample preparation by testing multiple lysis buffers and protease inhibitor combinations.

To differentiate between these possibilities, perform time-course experiments after protein synthesis inhibition and compare migration patterns with those of known N-terminal variants, as demonstrated in studies of the yeast Fra1 aminopeptidase .

How can I improve detection sensitivity for low-abundance YLR149C-A protein?

For enhanced detection of low-abundance YLR149C-A:

• Sample enrichment strategies:

  • Perform immunoprecipitation before Western blotting

  • Use subcellular fractionation to concentrate relevant compartments

  • Apply TCA precipitation to concentrate proteins from dilute samples

• Signal amplification methods:

  • Implement tyramide signal amplification (TSA) for immunofluorescence

  • Use high-sensitivity ECL substrates for Western blotting

  • Consider biotin-streptavidin detection systems

• Instrument optimization:

  • Extend exposure times with low-noise cameras

  • Use automated image enhancement algorithms

  • Apply deconvolution to fluorescence images

• Protocol modifications:

  • Increase antibody incubation time to 16 hours at 4°C

  • Reduce washing stringency slightly (without compromising specificity)

  • Optimize blocking conditions to reduce background while preserving signal

These approaches have been successfully employed for detecting low-abundance components in protein complexes similar to those studied in the human GID complex research .

How should I design co-immunoprecipitation experiments to identify YLR149C-A interacting partners?

For comprehensive identification of YLR149C-A interaction partners:

• Experimental design considerations:

  • Use both N- and C-terminally tagged versions to identify tag-position dependent artifacts

  • Compare native promoter versus overexpression systems

  • Include crosslinking conditions (DSP or formaldehyde) to capture transient interactions

  • Perform reciprocal co-IPs to confirm interactions

• Technical protocol optimization:

  • Test multiple lysis buffers with varying salt and detergent concentrations

  • Optimize antibody concentrations and bead volumes

  • Include RNase treatment to distinguish RNA-mediated interactions

  • Perform sequential IPs for higher purity

• Controls and validation:

  • Include IgG control, isotype control, and beads-only control

  • Validate key interactions with orthogonal methods (Y2H, BioID, FRET)

  • Quantify enrichment through label-free quantitative proteomics

This approach has been successfully implemented in studies of protein complexes like the human GID complex, where researchers identified distinct substrate modules targeting different proteins .

What are the methodological considerations for studying YLR149C-A degradation dynamics?

To accurately characterize YLR149C-A degradation kinetics:

• Chase assay considerations:

  • Implement the tetracycline-based promoter reference technique (PRT) to avoid global translation inhibitors

  • Include a long-lived reference protein (e.g., DHFR) for normalization

  • Design time points appropriate for expected half-life (typically 0, 15, 30, 60, 120 minutes)

  • Perform experiments in triplicate with results differing by ≤10%

• Pathway analysis tools:

  • Use specific proteasome inhibitors (MG132) versus lysosomal inhibitors

  • Compare degradation in strains lacking specific E3 ligases

  • Analyze ubiquitination patterns using ubiquitin-specific antibodies

  • Employ cycloheximide in parallel experiments as a methodological control

• Data acquisition and analysis:

  • Quantify band intensities using linear-range exposures

  • Plot degradation curves with first-order decay modeling

  • Calculate half-life values with confidence intervals

  • Normalize to t=0 for each experimental condition

This methodology has been effectively applied to study the degradation of proteins like AP-Aro10 and SP-Pck1 in yeast, revealing essential roles for specific aminopeptidases in their in vivo degradation .

How can I combine YLR149C-A antibody detection with growth phenotype analysis in yeast?

To correlate YLR149C-A protein levels with physiological outcomes:

• Growth condition optimization:

  • Establish baseline growth parameters in standard media using methods for determining growth rate and lag phase duration

  • Test various stress conditions (pH, temperature, nutrient limitation) to identify YLR149C-A-dependent phenotypes

  • Measure growth curves in aerobic shake flask cultures with appropriate controls

• Protein level monitoring:

  • Collect samples at defined timepoints during growth curve experiments

  • Perform quantitative Western blotting for YLR149C-A levels

  • Normalize protein levels to housekeeping controls and cell density

• Correlation analysis:

  • Plot YLR149C-A levels against growth parameters (growth rate, lag phase, survival)

  • Perform statistical analysis to determine significance of correlations

  • Compare wild-type with YLR149C-A mutants under identical conditions

• Experimental considerations:

  • Ensure cultures are inoculated to consistent starting densities (A600 of 0.1-0.3)

  • Wash inocula twice in sterile distilled water before use

  • Perform all experiments in triplicate to ensure reproducibility

This integrated approach has been successfully employed to study the relationship between protein expression and growth phenotypes in yeast under various stress conditions .

What methodological approaches should I use to study YLR149C-A interactions with the ubiquitin-proteasome system?

For investigating YLR149C-A interactions with the ubiquitin-proteasome system:

• In vitro ubiquitination assays:

  • Reconstitute ubiquitination reactions using purified components

  • Include E1, appropriate E2, candidate E3 ligases, ubiquitin, ATP, and purified YLR149C-A

  • Analyze ubiquitination patterns by immunoblotting with ubiquitin and YLR149C-A antibodies

  • Include controls lacking individual components to confirm specificity

• In vivo ubiquitination analysis:

  • Express His-tagged ubiquitin in yeast strains

  • Perform denaturing Ni-NTA pulldowns to isolate ubiquitinated proteins

  • Detect YLR149C-A using specific antibodies

  • Compare patterns between proteasome inhibitor-treated and untreated samples

• Proteasome association studies:

  • Perform co-immunoprecipitation with proteasome subunits

  • Analyze YLR149C-A presence in proteasome fractions from density gradients

  • Use proximity ligation assays to detect in situ interactions

This methodology parallels approaches used to study GID complex-mediated ubiquitination of substrates, where researchers demonstrated distinct substrate modules targeting different proteins for degradation .